role rapid diagnostics managing ebola epidemics 
ebola emerged west africa around december swept guinea sierra leone liberia giving rise confirmed probable suspected cases reported july case diagnoses epidemic relied polymerase chain reaction-based tests owing limited laboratory capacity local transport infrastructure delays sample collection test results available often days point-of-care rapid diagnostic tests offer potential substantially reduce delays review ebola rapid diagnostic tests approved world health organization currently development rapid diagnostic tests allow early triaging patients thereby reducing potential nosocomial transmission addition despite lower test accuracy rapid diagnostic test-based diagnosis may beneficial contexts reduced time spent uninfected individuals health-care settings may increased risk infection also frees hospital beds use mathematical modelling explore potential benefits diagnostic testing strategies involving rapid diagnostic tests alone combination polymerase chain reaction testing analysis indicates use rapid diagnostic tests sensitivity specificity comparable currently development always enhances control whether evaluated health-care-unit population level tests available throughout recent epidemic estimate sierra leone use combination confirmatory polymerase chain-reaction testing might reduced scale epidemic third 
